Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study

Area of Science:

• Dermatopathology
• Oncology
• Immunohistochemistry

Background:

• Nevus cell components are present in up to 40% of melanomas.
• The pathobiology of these components and their relation to malignant potential are poorly understood.

Purpose of the Study:

• To investigate the pathobiology of nevus cell components in various nevus types using immunohistochemical markers.
• To assess the reactivity of melanoma-specific antibodies in different nevus subtypes.

Main Methods:

• Studied 44 nevi (typical, dysplastic, congenital, Spitz) using avidin-biotin immunohistochemistry.
• Utilized monoclonal and polyclonal antibodies: HMB.45, S-100 protein, RAP-5, EMA, and NSE on formalin-fixed, paraffin-embedded tissues.

Main Results:

• HMB.45 showed heterogeneous reactivity in junctional components of dysplastic, congenital, and some Spitz nevi, with one Spitz nevus mimicking melanoma staining.
• S-100 protein labeled nevomelanocytes but was heterogeneous in half of dysplastic nevi and atypical junctional components of congenital nevi.
• NSE stained Spitz nevi differentially; junctional nevomelanocytes in some congenital nevi showed reactivity similar to dysplastic nevi.

Conclusions:

• Immunohistochemical analysis reveals distinct reactivity patterns of melanoma-associated markers in different nevus types.
• Heterogeneous expression of HMB.45 and S-100 protein in nevus components, particularly in dysplastic and congenital nevi, may indicate varying malignant potential.
• Further research is needed to elucidate the pathobiology and clinical significance of these findings in melanoma development.